NCB Pharma Private Limited
About NCB Pharma Private Limited
Data last updated:
NCB Pharma Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 22 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2021PTC147981. Its GSTIN is 36AAHCN3968N1ZP (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Narasimhulu Bhumireddy and Chandrasekhar Bhumireddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.6 Sindhura Colony Kapra Secunderabad, Telangana, India – 500062.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.96 Lakh, a growth of 123% compared to the previous year. For the same year it recorded a net profit of ₹12,871 (net margin 0.3%) and EBITDA of ₹1.22 Lakh (EBITDA margin 3%).
Company details
Contact details
NCB Pharma Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.6 Sindhura Colony Kapra Secunderabad, Telangana, India – 500062
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of NCB Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of NCB Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of NCB Pharma Private Limited, buy the company report.
Financials of NCB Pharma Private Limited
FY 2025 filings availableNCB Pharma Private Limited reported revenue of ₹39.96 Lakh (up 123% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 123% in the latest year. EBITDA rose 187% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12,871 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of NCB Pharma Private Limited, buy the company report.
Board of directors of NCB Pharma Private Limited
NCB Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narasimhulu Bhumireddy Also directs: Tezos Organics Private Limited | Director | 22 Jan 2021 | 5 Years 9 Months | Current |
| Chandrasekhar Bhumireddy Also directs: Tezos Organics Private Limited | Director | 22 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
NCB Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Super Star Laboratories Private Limited | ₹40.44 Lakh (FY 2016) | -28.0% | New Delhi, Delhi, India | |||
| Chemyzolab Private Limited | ₹40.33 Lakh (FY 2025) | 5.0% | Bangalore, Karnataka, India | |||
| Venkateshwara Chemical Industries Private Limited | ₹40.13 Lakh (FY 2025) | -99.0% | Ghaziabad, Uttar Pradesh, India | |||
| NCB Pharma Private Limitedthis company | ₹39.96 Lakh (FY 2025) | ₹12,871 | 0.3% | 123.0% | Secunderabad, Telangana, India | |
| Alum and Allied Chemicals Private Limited | ₹39.76 Lakh (FY 2025) | -60.0% | Pollachi, Tamil Nadu, India | |||
| Coris Chemicals and Pharmaceuticals Private Limited | ₹39.7 Lakh (FY 2025) | 34.0% | Surat, Gujarat, India | |||
| Marathwada Chemical Industries Private Limited | ₹39.54 Lakh (FY 2025) | -96.0% | Aurangabad, Maharashtra, India |
To see the full peer comparison of NCB Pharma Private Limited, buy the company report.
Auditor
NCB Pharma Private Limited is audited by A R M R & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A R M R & ASSOCIATES | FY 2022 | 018379S |
Legal cases
No court or tribunal cases involving NCB Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for NCB Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
NCB Pharma Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
NCB Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCN3968N1ZP | Telangana | Active | 16 Mar 2021 |
To see the full GST registrations and return filing status of NCB Pharma Private Limited, buy the company report.
Recent activity
NCB Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Chandrasekhar Bhumireddy was appointed as Director on 22 Jan 2021.
Frequently asked questions
NCB Pharma is an active private limited company based in Secunderabad, Telangana, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 22 January 2021 (5+ years old) and is registered under CIN U74999TG2021PTC147981.
NCB Pharma has 2 current directors:
- Narasimhulu Bhumireddy - Director
- Chandrasekhar Bhumireddy - Director
The latest financial statements of NCB Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of NCB Pharma is 36AAHCN3968N1ZP, registered in Telangana.
The CIN (Corporate Identification Number) of NCB Pharma is U74999TG2021PTC147981. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
NCB Pharma was incorporated on 22 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of NCB Pharma by revenue are Super Star Laboratories Private Limited, Chemyzolab Private Limited, Venkateshwara Chemical Industries Private Limited, Alum and Allied Chemicals Private Limited, Coris Chemicals and Pharmaceuticals Private Limited and 1 more, all in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chandrasekhar Bhumireddy was appointed as Director on 22 Jan 2021. Narasimhulu Bhumireddy was appointed as Director on 22 Jan 2021.
The registered office of NCB Pharma is at Plot No.6 Sindhura Colony Kapra Secunderabad, Telangana, India – 500062.
NCB Pharma operates in the chemicals and materials industry, in the industrial chemicals segment.
NCB Pharma can be reached at its registered office: Plot No.6 Sindhura Colony Kapra Secunderabad, Telangana, India – 500062.